Persistent factor VIII-dependent factor X activation on endothelial cells is independent of von Willebrand factor

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 3, 2008, Pages 190-196

  Brinkman, Herm Jan M ^a   Van Mourik, Jan A ^a,b   Mertens, Koen ^a,c  

^a SANQUIN RESEARCH   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Coagulation; Endothelial cells ; Factor VIII stability; Factor X activation decay; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; PHENYLALANINE; THROMBIN; TYROSINE; VON WILLEBRAND FACTOR;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CELL ACTIVATION; CELL SURFACE; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KINETICS; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN VARIANT; THROMBOCYTE; THROMBOCYTE ACTIVATION; UMBILICAL VEIN;

BLOOD COAGULATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FACTOR VIIIA; FACTOR XA; HUMANS; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

EID: 41849090451     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282faa8c1     Document Type: Article

References (37)

1. Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 2003; 23:17-25.
2. Ahmad SS, London FS, Walsh PN. The assembly of the factor X-activating complex on activated human platelets. J Thromb Haemost 2003; 1:48-59.
3. Stern DM, Drillings M, Kisiel W, Nawroth P, Nossel HL, LaGamma KS. Activation of factor IX bound to cultured bovine aortic endothelial cells. Proc Natl Acad Sci U S A 1984; 81:913-917.
4. Varadi K, Elodi S. Formation and functioning of the factor IXa-VIII complex on the surface of endothelial cells. Blood 1987; 69:442-445.
5. Brinkman HJ, Mertens K, Holthuis J, Zwart-Huinink LA, Grijm K, van Mourik JA. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes. Br J Haematol 1994; 87:332-342.
6. Koppelman SJ, Koedam JA, van Wijnen M, Stern DM, Nawroth PP, Sixma JJ, Bouma BN. Von Willebrand factor as a regulator of intrinsic factor X activation. J Lab Clin Med 1994; 123:585-593.
7. Ananyeva NM, Kouiavskaia DV, Shima M, Saenko EL. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood 2002; 99:4475-4485.
8. Brinkman HJ, Mertens K, van Mourik JA. Phospholipid-binding domain of factor VIII is involved in endothelial cell-mediated activation of factor X by factor IXa. Arterioscler Thromb Vasc Biol 2002; 22:511-516.
9. Fay PJ. Activation of factor VIII and mechanisms of cofactor action. Blood 2004; 18:1-15.
10. Nuenschwander P, Jesty J. A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X. Blood 1988; 72:1761-1770.
11. Neuenschwander PF, Jesty J. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate. Arch Biochem Biophys 1992; 296:426-434.
12. Donath MJ, Lenting PJ, Van Mourik JA, Mertens K. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740. Eur J Biochem 1996; 240:365-372.
13. Lollar P, Parker ET. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog. J Biol Chem 1991; 266:12481-12486.
14. Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem 1991; 266:8957-8962.
15. Fay PJ, Beattie TL, Regan LM, O'Brien LM, Kaufman RJ. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis. J Biol Chem 1996; 271:6027-6032.
16. Brinkman HJ, Koster P, Mertens K, van Mourik JA. Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation. Biochem J 1997; 323:735-740.
17. Parker ET, Doering CB, Lollar P. A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation. J Biol Chem 2006; 281:13922-13930.
18. Koedam JA, Hamer RJ, Beeser-Visser NH, Bouma BN, Sixma JJ. The effect of von Willebrand factor on activation of factor VIII by factor Xa. Eur J Biochem 1990; 189:229-234.
19. Lenting PJ, Donath MJ, van Mourik JA, Mertens K. Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII. J Biol Chem 1994; 269:7150-7155.
20. Saenko EL, Scandella D. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor. J Biol Chem 1995; 270:13826-13833.
21. Hill-Eubanks DC, Lollar P. Von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. J Biol Chem 1990; 265:17854-17858.
22. Raut S, Villard S, Grailly S, Gilles JG, Granier C, Saint-Remy JM, Barrowcliffe TW. Antiheavy-chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor. Thromb Haemost 2003; 90:385-397.
23. Rondaij MG, Bierings R, Kragt A, van Mourik JA, Voorberg J. Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26:1002-1007.
24. Leyte A, van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP, Mertens K, van Mourik JA. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1991; 266:740-746.
25. Donath MJ, de Laaf RT, Biessels PT, Lenting PJ, van de Loo JW, van Mourik JA, et al. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa. Biochem J 1995; 312:49-55.
26. Vossen RC, Feijge MA, Heemskerk JW, van Dam-Mieras MC, Hornstra G, Zwaal RF. Long-term fatty acid modification of endothelial cells: implications for arachidonic acid distribution in phospholipid classes. J Lipid Res 1993; 34:409-420.
27. Bevers EM, Comfurius P, Zwaal RF. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736:57-66.
28. Lamphear BJ, Fay PJ. Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer. J Biol Chem 1992; 267:3725-3730.
29. Curtis JE, Helgerson SL, Parker ET, Lollar P. Isolation and characterization of thrombin-activated human factor VIII. J Biol Chem 1994; 269:6246-6251.
30. Heimark RL, Schwartz SM. Binding of coagulation factors IX and X to the endothelial cell surface. Biochem Biophys Res Commun 1983; 111:723-731.
31. Cheung WF, Hamaguchi N, Smith KJ, Stafford DW. The binding of human factor IX to endothelial cells is mediated by residues 3-11. J Biol Chem 1992; 267:20529-20531.
32. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993; 7:52-62.
33. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91:3527-3561.
34. Esmon CT. Regulation of blood coagulation. Biochim Biophys Acta 2000; 1477:349-360.
35. Dahlback B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Lett 2005; 579:3310-3316.
36. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006; 32 (Suppl 1):32-38.
37. Hackeng TM, Tans G, Koppelman SJ, de Groot PG, Rosing J, Bouma BN. Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin. Biochem J 1996; 319:399-405.